Ultimate Anti-Aging Peptide Stack: Epithalon, GHK-Cu, MOTS-c, Humanin & Ipamorelin

Aging is not a single process — it is dozens of simultaneous biological failures compounding over decades. Telomere shortening, mitochondrial dysfunction, declining growth hormone, accumulating senescent cells, collagen degradation, and chronic low-grade inflammation (inflammaging) all contribute to the phenotype we associate with getting old. The most sophisticated anti-aging peptide stacks address multiple hallmarks simultaneously, which is why combining five targeted compounds produces results no single peptide can achieve alone.

This protocol covers the full science and practical application of the ultimate anti-aging peptide stack: epithalon, GHK-Cu, MOTS-c, humanin, and ipamorelin.

The Five Pillars of Anti-Aging Peptide Science

Before diving into each compound, it helps to understand the five biological targets this stack addresses:

1. Telomere maintenance — the rate at which chromosomal end-caps shorten determines cellular lifespan
2. Mitochondrial function — energy production efficiency and mitochondrial biogenesis
3. GH/IGF-1 axis restoration — declining growth hormone accelerates nearly every aging marker
4. Collagen and extracellular matrix quality — structural proteins determine tissue integrity
5. Gene expression regulation — epigenetic control of repair, antioxidant, and anti-inflammatory genes

Each peptide in this stack maps to one or more of these pillars.

Epithalon: Telomere Lengthening and Pineal Restoration

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian scientist Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology. Over three decades of research — including human clinical trials — have produced findings that would be remarkable if confirmed by Western peer review.

Epithalon's primary mechanisms include:

• Activation of telomerase enzyme, which rebuilds shortened telomeres
• Stimulation of melatonin production via the pineal gland (melatonin being a potent antioxidant and sleep regulator)
• Normalization of the hypothalamic-pituitary axis
• Reduction of lipid peroxidation and oxidative damage

The most cited human study followed elderly patients over several years and found that epithalon treatment correlated with reduced cancer incidence and improved biomarkers of biological aging. While replication by independent Western groups remains limited, the mechanistic rationale for telomerase activation is well-established.

Protocol: Epithalon is typically run in 10-day courses, 2–4 times per year. The standard dose is 5–10 mg per day via subcutaneous injection or intranasal administration. Many longevity practitioners favor spring and autumn cycles to align with circadian and seasonal rhythms.

GHK-Cu: Gene Expression and Collagen Architecture

Copper peptide GHK-Cu is one of the best-studied anti-aging compounds in dermatology and regenerative medicine. As a naturally occurring tripeptide in human plasma, its decline from roughly 200 ng/mL at age 20 to 80 ng/mL by age 60 correlates directly with deteriorating wound healing and skin quality.

What makes GHK-Cu especially powerful in an anti-aging context is its breadth. Research by Loren Pickart identified over 4,000 genes regulated by GHK-Cu, including:

• Genes controlling collagen I and III synthesis
• Antioxidant enzymes (superoxide dismutase, catalase)
• Anti-inflammatory cytokines
• Nerve growth factor and brain-derived neurotrophic factor (BDNF)
• DNA repair mechanisms

For anti-aging purposes, GHK-Cu serves as a broad gene-expression modulator that reinforces biological youth at the cellular level. It is the collagen and cellular-signaling layer of the stack.

Protocol: 1–2 mg/day subcutaneously for systemic anti-aging benefits. Topical GHK-Cu (1–2% serum applied to skin) provides excellent local anti-aging effects for skin quality and is a cost-effective way to use this peptide. The combination of systemic and topical is ideal. For skin-specific benefits, see best peptides for skin collagen.

MOTS-c: Mitochondrial-Derived Anti-Aging Peptide

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) represents a newer class of anti-aging peptides: mitochondria-derived peptides (MDPs). Encoded within mitochondrial DNA, MOTS-c regulates metabolic homeostasis by translocating to the nucleus under stress conditions and modulating gene expression there.

Research published in Cell Metabolism by Changhan Lee's lab at USC demonstrated that MOTS-c:

• Activates AMPK (the master energy-sensing enzyme also activated by caloric restriction and metformin)
• Improves insulin sensitivity and glucose metabolism
• Increases physical performance in aged mice comparably to exercise training
• Reduces age-related weight gain

In human contexts, MOTS-c plasma levels decline with age and are associated with longevity in centenarian populations. This makes it a compelling addition to any anti-aging stack aimed at metabolic health.

Protocol: 5–10 mg per week subcutaneously, split into 2–3 injections. MOTS-c is best used cyclically — 4–8 weeks on, 4 weeks off — as its mechanisms involve receptor sensitization that may attenuate with continuous use.

Humanin: Neuroprotection and Insulin Sensitization

Humanin is another mitochondria-derived peptide encoded in the 16S rRNA region of mitochondrial DNA. Its decline with aging parallels that of MOTS-c, and IGF-1 binding protein 3 (IGFBP-3) acts as a delivery mechanism that gets humanin to target tissues.

Key anti-aging effects of humanin include:

• Neuroprotection against amyloid-beta toxicity (relevant for Alzheimer's prevention)
• Improvement of insulin sensitivity
• Cardioprotection via reduction of oxidative stress in cardiac tissue
• Reduction of hypothalamic inflammation linked to metabolic aging
• Protection of mitochondrial membrane integrity

Humanin concentrations in centenarians are substantially higher than in average aging populations, and in offspring of centenarians — suggesting a genetic component to humanin production that also responds to exogenous supplementation.

Protocol: 2–4 mg per week subcutaneously. Like MOTS-c, humanin is used cyclically. The combination of MOTS-c + humanin creates a synergistic mitochondrial protection layer: MOTS-c primarily handles metabolic signaling while humanin handles neuroprotection and mitochondrial membrane integrity.

Ipamorelin: Restoring the GH/IGF-1 Axis

Growth hormone declines at approximately 15% per decade after age 30. By age 60, most adults produce less than a third of the GH they did in their twenties. This somatopause drives muscle wasting, fat accumulation, reduced bone density, poor sleep quality, and cognitive decline.

Ipamorelin is a selective GH secretagogue that stimulates the pituitary gland to release GH pulses without meaningfully elevating cortisol, prolactin, or other stress hormones — a cleaner profile than older secretagogues like GHRP-2 or GHRP-6.

For anti-aging purposes, ipamorelin is best combined with a GHRH analog (CJC-1295 without DAC or modified GRF 1-29) to amplify GH pulse magnitude. The two peptides work on complementary receptors to produce synergistic GH release.

Protocol: 200–300 mcg ipamorelin + 200 mcg CJC-1295 (no DAC) before sleep, 5 days on / 2 days off. This timing capitalizes on the natural GH pulse that occurs in the first hours of sleep, producing more physiological GH elevation than daytime dosing.

Benefits relevant to aging: improved body composition, enhanced sleep quality (particularly slow-wave sleep), increased bone density, improved skin thickness, and better cognitive function via GH/IGF-1-mediated neurogenesis.

The Complete Ultimate Anti-Aging Protocol

Daily (ongoing):

• GHK-Cu: 1 mg subcutaneously each morning
• Ipamorelin + CJC-1295: 200–300 mcg each before sleep

Cyclical (4x per year, 10-day courses):

• Epithalon: 5–10 mg per day for 10 consecutive days

Ongoing, 8 weeks on / 4 weeks off:

• MOTS-c: 5 mg twice weekly
• Humanin: 2 mg twice weekly (can inject same day as MOTS-c)

Quarterly biomarker tracking is essential to gauge protocol effectiveness. Key markers: IGF-1, fasting insulin, HbA1c, telomere length (TruDiagnostic or similar), inflammatory markers (hsCRP, IL-6), and DEXA body composition.

Lifestyle Foundations That Amplify Results

Peptides work within the context of overall biology. This stack will underperform in someone who is sleep-deprived, sedentary, and eating ultra-processed food. The non-negotiable foundations:

• Sleep: 7–9 hours, consistent schedule. GH release is tightly linked to sleep architecture.
• Resistance training: MOTS-c and ipamorelin effects on muscle are magnified by progressive overload.
• Caloric moderation: MOTS-c and humanin work through pathways also activated by caloric restriction. Chronic overfeeding blunts their effects.
• Stress management: Chronic cortisol elevation suppresses GH pulsatility and accelerates telomere shortening.

For a broader view of peptide use for older adults, see best peptides for over 40.

Frequently Asked Questions

Q: Is the evidence for these peptides strong enough to justify use in healthy people? The evidence base varies. GHK-Cu and ipamorelin have robust human and animal research. Epithalon has primarily Russian clinical data. MOTS-c and humanin are newer, with compelling preclinical and some human data. Informed individuals with low risk tolerance should start with the better-studied compounds and add newer ones as evidence matures.

Q: Can women use all five peptides in this stack? Yes. None of these peptides are sex-hormone-related. GHK-Cu, epithalon, MOTS-c, and humanin have been studied in both sexes. Ipamorelin/CJC-1295 are used by both men and women. Dosing adjustments are not typically required, though some practitioners suggest women use slightly lower ipamorelin doses (150–200 mcg) initially.

Q: How long before anti-aging benefits become measurable? Subjective improvements (sleep quality, energy, skin) are often noticed within 4–8 weeks. Objective biomarker changes (IGF-1 increase, body composition shifts) are typically measurable after 3–6 months of consistent use. Telomere-related changes require longer observation windows — 12–24 months.

Q: Should I take anything to support this stack? NAD+ precursors (NMN or NR), omega-3 fatty acids, vitamin D3/K2, and magnesium are commonly stacked alongside anti-aging peptides. Rapamycin (low-dose) is used by some longevity practitioners and may have synergistic effects with this stack, but it carries more significant immunosuppressive risks and requires physician supervision.

Q: Where can I learn more about individual peptides in this stack? See the individual guides: best peptides for anti-aging, thymosin alpha-1 guide, and sermorelin guide for related anti-aging peptide context.